Nomura Asset Management
SRPT icon

Nomura Asset Management’s Sarepta Therapeutics SRPT Stock Holding History

Nomura Asset Management’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-13,430
Closed -$1.02M – 984
2021
Q1 		$1M Hold
13,430
– – 0.01% 832
2020
Q4 		$2.29M Buy
13,430
+1,300
+11% +$193K 0.02% 658
2020
Q3 		$1.7M Hold
12,130
– – 0.01% 667
2020
Q2 		$1.95M Sell
12,130
-170
-1% -$23.1K 0.02% 588
2020
Q1 		$1.2M Hold
12,300
– – 0.01% 652
2019
Q4 		$1.59M Hold
12,300
– – 0.01% 694
2019
Q3 		$926K Buy
+12,300
New +$1.45M 0.01% 781

Other funds holding SRPT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Nomura Asset Management's SRPT Position: Q2 2021 in Review

Nomura Asset Management sold out of Sarepta Therapeutics (SRPT) in Q2 2021, closing a stake of 13,430 shares — an estimated $1.02M sold.

Nomura Asset Management first reported a position in SRPT in Q3 2019 and held it in 7 quarters. The position peaked at $2.29M in Q4 2020. 330 funds tracked by Wall St. Rank hold SRPT as of Q2 2021.

  • Nomura Asset Management reported no remaining Sarepta Therapeutics position as of Q2 2021 after selling out during the quarter.
  • Nomura Asset Management sold 13,430 Sarepta Therapeutics shares in Q2 2021, an estimated $1.02M.
  • Nomura Asset Management first reported a position in Sarepta Therapeutics in Q3 2019 and held it in 7 quarters.
  • Nomura Asset Management's Sarepta Therapeutics position peaked at $2.29M in Q4 2020.
  • 330 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2021.

Based on Nomura Asset Management's 13F filing for Q2 2021, filed 6 Aug 2021.